- Home
- BKYI vs ATNF Comparison
BKYI vs ATNF Comparison
Compare BKYI & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- ATNF
- Stock Information
- Founded
- BKYI 1993
- ATNF 2016
- Country
- BKYI United States
- ATNF United States
- Employees
- BKYI N/A
- ATNF N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- ATNF Health Care
- Exchange
- BKYI Nasdaq
- ATNF Nasdaq
- Market Cap
- BKYI 3.8M
- ATNF 4.1M
- IPO Year
- BKYI 1997
- ATNF N/A
- Fundamental
- Price
- BKYI $0.72
- ATNF $0.90
- Analyst Decision
- BKYI
- ATNF
- Analyst Count
- BKYI 0
- ATNF 0
- Target Price
- BKYI N/A
- ATNF N/A
- AVG Volume (30 Days)
- BKYI 239.0K
- ATNF 137.8K
- Earning Date
- BKYI 06-13-2025
- ATNF 05-14-2025
- Dividend Yield
- BKYI N/A
- ATNF N/A
- EPS Growth
- BKYI N/A
- ATNF N/A
- EPS
- BKYI N/A
- ATNF N/A
- Revenue
- BKYI $6,929,571.00
- ATNF N/A
- Revenue This Year
- BKYI $25.12
- ATNF N/A
- Revenue Next Year
- BKYI N/A
- ATNF N/A
- P/E Ratio
- BKYI N/A
- ATNF N/A
- Revenue Growth
- BKYI N/A
- ATNF N/A
- 52 Week Low
- BKYI $0.52
- ATNF $0.66
- 52 Week High
- BKYI $3.68
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- BKYI 36.02
- ATNF 44.36
- Support Level
- BKYI $0.66
- ATNF $0.80
- Resistance Level
- BKYI $0.84
- ATNF $0.94
- Average True Range (ATR)
- BKYI 0.09
- ATNF 0.12
- MACD
- BKYI 0.01
- ATNF 0.02
- Stochastic Oscillator
- BKYI 45.45
- ATNF 51.06
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.